Market closed
Hims & Hers Health/$HIMS
Hims & Hers Health shares are trading higher following positive sentiment from analysts highlighting the company's growth potential and strategic positioning in the healthcare sector.
6 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
Ticker
$HIMS
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
1,637
Website
HIMS Metrics
BasicAdvanced
$5.9B
50.18
$0.53
1.37
-
Price and volume
Market cap
$5.9B
Beta
1.37
52-week high
$72.98
52-week low
$11.20
Average daily volume
22M
Financial strength
Current ratio
1.788
Quick ratio
1.384
Long term debt to equity
1.984
Total debt to equity
2.38
Management effectiveness
Return on assets (TTM)
7.18%
Return on equity (TTM)
30.71%
Valuation
Price to earnings (TTM)
50.185
Price to revenue (TTM)
3.906
Price to book
12.37
Price to tangible book (TTM)
18.4
Price to free cash flow (TTM)
29.081
Growth
Revenue change (TTM)
69.33%
Earnings per share change (TTM)
-573.21%
3-year revenue growth (CAGR)
75.77%
3-year earnings per share growth (CAGR)
-2.62%
What the Analysts think about HIMS
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Hims & Hers Health stock.
HIMS Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
HIMS Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
HIMS News
AllArticlesVideos
Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy
Seeking Alpha·1 day ago
The FDA has posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro
WSJ·2 days ago
Hims & Hers: Top Pick For The Next Decade
Seeking Alpha·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Hims & Hers Health stock?
Hims & Hers Health (HIMS) has a market cap of $5.9B as of April 25, 2025.
What is the P/E ratio for Hims & Hers Health stock?
The price to earnings (P/E) ratio for Hims & Hers Health (HIMS) stock is 50.18 as of April 25, 2025.
Does Hims & Hers Health stock pay dividends?
No, Hims & Hers Health (HIMS) stock does not pay dividends to its shareholders as of April 25, 2025.
When is the next Hims & Hers Health dividend payment date?
Hims & Hers Health (HIMS) stock does not pay dividends to its shareholders.
What is the beta indicator for Hims & Hers Health?
Hims & Hers Health (HIMS) has a beta rating of 1.37. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.